glp 1 drugs and vision loss Sudden or blurring while taking GLP-1s should be treated as a medical emergency, an expert told Newsweek Vision loss risks in patients

Coito, C., Diamond, D

Drugs.com, May 2026) SEMALEAN Found Function Improved Even as Lean Mass Dipped The SEMALEAN trial produced one of the more reassuring findings in this area: lean mass declined initially then stabilised , while handgrip strength improved by 4.5 kg and sarcopenic obesity prevalence fell from 49% to 33% over twelve months

*Correspondence: Elsa Sanchez-Lopez, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers